These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

320 related articles for article (PubMed ID: 3935193)

  • 21. [Long-term results of short course chemotherapy of pulmonary tuberculosis. Second study-B: results at 6 years after the end of 4-9 month chemotherapy of pulmonary tuberculosis].
    Baba H; Shinkai A; Izuchi R; Azuma Y
    Kekkaku; 1987 Oct; 62(10):511-20. PubMed ID: 3444194
    [No Abstract]   [Full Text] [Related]  

  • 22. Using treatment failure under effective directly observed short-course chemotherapy programs to identify patients with multidrug-resistant tuberculosis.
    Becerra MC; Freeman J; Bayona J; Shin SS; Kim JY; Furin JJ; Werner B; Sloutsky A; Timperi R; Wilson ME; Pagano M; Farmer PE
    Int J Tuberc Lung Dis; 2000 Feb; 4(2):108-14. PubMed ID: 10694087
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Short-course chemotherapy for pulmonary tuberculosis (author's transl)].
    Yamamoto K
    Kekkaku; 1978 Aug; 53(8):401-6. PubMed ID: 703041
    [No Abstract]   [Full Text] [Related]  

  • 24. [Intermittent method of chemotherapy of pulmonary tuberculosis (immediate and remote results)].
    Rabukhin AE; Gol'dshtein VD; Prokhorov EP; Karpukhina NV
    Klin Med (Mosk); 1977 Dec; 55(12):30-5. PubMed ID: 604638
    [No Abstract]   [Full Text] [Related]  

  • 25. Changing concepts in tuberculosis chemotherapy.
    Davidson PT
    Compr Ther; 1977 Dec; 3(12):38-44. PubMed ID: 923209
    [No Abstract]   [Full Text] [Related]  

  • 26. [Response of Mycobacteria tuberculosis isolated from chronic patients to single or combined drugs].
    Fanea E; Vaida T; Buzilă A; Bukşe E; Câmpeanu L
    Rev Ig Bacteriol Virusol Parazitol Epidemiol Pneumoftiziol Pneumoftiziol; 1982; 31(4):335-42. PubMed ID: 6304848
    [No Abstract]   [Full Text] [Related]  

  • 27. Outcome of chemotherapy in 107 patients with pulmonary tuberculosis resistant to isoniazid and rifampin.
    Park SK; Kim CT; Song SD
    Int J Tuberc Lung Dis; 1998 Nov; 2(11):877-84. PubMed ID: 9848607
    [TBL] [Abstract][Full Text] [Related]  

  • 28. [Pulmonary tuberculosis. 2. Therapy].
    Bölcskei P
    Fortschr Med; 1983 Jun; 101(23):1075-80, 1090. PubMed ID: 6411560
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Chemotherapy of pulmonary tuberculosis in Britain.
    Drug Ther Bull; 1988 Jan; 26(1):1-4. PubMed ID: 3123192
    [No Abstract]   [Full Text] [Related]  

  • 30. Short course chemotherapy (SCC): will it be our answer?
    Malik SK; Gilhotra RC
    Indian J Chest Dis Allied Sci; 1985; 27(2):132-3. PubMed ID: 3870808
    [No Abstract]   [Full Text] [Related]  

  • 31. The hunt for the elusive surrogate marker of sterilizing activity in tuberculosis treatment.
    Burman WJ
    Am J Respir Crit Care Med; 2003 May; 167(10):1299-301. PubMed ID: 12738594
    [No Abstract]   [Full Text] [Related]  

  • 32. [Toward a modern treatment of pulmonary tuberculosis. 2. Bacteriologic and pharmacologic bases and short-term treatment].
    Zegaya M
    Tunis Med; 1984 Nov; 62(7):487-94. PubMed ID: 6442475
    [No Abstract]   [Full Text] [Related]  

  • 33. [Shorter treatment of pulmonary tuberculosis is only acceptable with at least 4 drugs in the initial combination of tuberculostatic agents].
    Veen J
    Ned Tijdschr Geneeskd; 1996 Nov; 140(44):2164-7. PubMed ID: 8984351
    [No Abstract]   [Full Text] [Related]  

  • 34. [Bactericidal therapy in patients with tuberculosis].
    Krasnov VA; Ursov IG
    Probl Tuberk Bolezn Legk; 2004; (3):21-6. PubMed ID: 15338895
    [No Abstract]   [Full Text] [Related]  

  • 35. [Bacterial excretion and the bacteriostatic activity of the blood in the chemotherapy of middle-aged and elderly tuberculosis patients].
    Ginzburg TS; Iakimets VP
    Probl Tuberk; 1983 May; (5):57-61. PubMed ID: 6408638
    [No Abstract]   [Full Text] [Related]  

  • 36. [Evaluation of early results of treatment of pulmonary tuberculosis in Mycobacterium-positive patients. Comparison of the results of 3- and 4-drug treatment].
    Martyniak K; Wyczółkowski M; Bochiński T
    Pneumonol Pol; 1985 Apr; 53(4):195-201. PubMed ID: 3931056
    [No Abstract]   [Full Text] [Related]  

  • 37. [Early and late results of 6-month treatment of pulmonary tuberculosis with various drug combinations].
    Rogowski J; Zierski M; Bek E; Snider DE; Long MW
    Pneumonol Pol; 1982 Sep; 50(9):425-35. PubMed ID: 7163000
    [No Abstract]   [Full Text] [Related]  

  • 38. [The influence of drug-resistance in antituberculosis chemotherapy (author's transl)].
    Cui GC
    Zhonghua Jie He He Hu Xi Xi Ji Bing Za Zhi; 1979; 2(4):251-3. PubMed ID: 122146
    [No Abstract]   [Full Text] [Related]  

  • 39. [Factors relating to the incidence of drug resistance for anti-tuberculosis drugs during chemotherapy. 2].
    Yamamoto M
    Kekkaku; 1970 Nov; 45(11):359-66. PubMed ID: 4992936
    [No Abstract]   [Full Text] [Related]  

  • 40. [New cases of pulmonary tuberculosis treatment within DOTS strategy].
    Zhangireev AA; Ismailov ShSh; Berikova EM
    Probl Tuberk; 2000; (3):23-5. PubMed ID: 10900979
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.